179 related articles for article (PubMed ID: 29691706)
21. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.
Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F
PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023
[TBL] [Abstract][Full Text] [Related]
23. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
[TBL] [Abstract][Full Text] [Related]
24. The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness.
Cuthbert JJ; Kearsley JW; Kazmi S; Kallvikbakka-Bennett A; Weston J; Davis J; Rimmer S; Clark AL
Clin Res Cardiol; 2019 Feb; 108(2):185-193. PubMed ID: 30091083
[TBL] [Abstract][Full Text] [Related]
25. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials.
Çolak Y; Nordestgaard BG; Lange P; Vestbo J; Afzal S
Am J Respir Crit Care Med; 2022 Aug; 206(3):271-280. PubMed ID: 35438616
[No Abstract] [Full Text] [Related]
27. Fixed ratio or lower limit of normal for the FEV
Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
[TBL] [Abstract][Full Text] [Related]
28. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts.
Afzal S; Brøndum-Jacobsen P; Bojesen SE; Nordestgaard BG
BMJ; 2014 Nov; 349():g6330. PubMed ID: 25406188
[TBL] [Abstract][Full Text] [Related]
29. Lung volume indices predict morbidity in smokers with preserved spirometry.
Zeng S; Tham A; Bos B; Jin J; Giang B; Arjomandi M
Thorax; 2019 Feb; 74(2):114-124. PubMed ID: 30030304
[TBL] [Abstract][Full Text] [Related]
30. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
31. Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease.
Manganas H; Lacasse Y; Bourgeois S; Perron J; Dagenais F; Maltais F
Can Respir J; 2007; 14(1):19-24. PubMed ID: 17315054
[TBL] [Abstract][Full Text] [Related]
32. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
[TBL] [Abstract][Full Text] [Related]
33. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.
Durup D; Jørgensen HL; Christensen J; Tjønneland A; Olsen A; Halkjær J; Lind B; Heegaard AM; Schwarz P
J Clin Endocrinol Metab; 2015 Jun; 100(6):2339-46. PubMed ID: 25710567
[TBL] [Abstract][Full Text] [Related]
34. No association of 25-hydroxyvitamin D with exacerbations in primary care patients with COPD.
Puhan MA; Siebeling L; Frei A; Zoller M; Bischoff-Ferrari H; Ter Riet G
Chest; 2014 Jan; 145(1):37-43. PubMed ID: 24008868
[TBL] [Abstract][Full Text] [Related]
35. Blood biomarkers as predictors of long-term mortality in COPD.
Mendy A; Forno E; Niyonsenga T; Gasana J
Clin Respir J; 2018 May; 12(5):1891-1899. PubMed ID: 29227024
[TBL] [Abstract][Full Text] [Related]
36. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality - A prospective study.
Torén K; Andersson M; Olin AC; Blanc PD; Järvholm B
Respir Med; 2018 Nov; 144():36-41. PubMed ID: 30366582
[TBL] [Abstract][Full Text] [Related]
37. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
Husebø GR; Grønseth R; Lerner L; Gyuris J; Hardie JA; Bakke PS; Eagan TM
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298399
[TBL] [Abstract][Full Text] [Related]
38. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.
Quint JK; Donaldson GC; Wassef N; Hurst JR; Thomas M; Wedzicha JA
BMC Pulm Med; 2012 Jun; 12():28. PubMed ID: 22726649
[TBL] [Abstract][Full Text] [Related]
39. Young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival: a population-based prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29449425
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study.
Çolak Y; Afzal S; Nordestgaard BG; Lange P
Am J Respir Crit Care Med; 2015 Jul; 192(2):172-81. PubMed ID: 25914942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
